milrinone has been researched along with Fallot's Tetralogy in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare levosimendan with milrinone to prevent low cardiac output syndrome in patients undergoing tetralogy of Fallot correction." | 9.51 | [Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot]. ( Dosta-Herrera, JJ; Gutiérrez-Riveroll, KI; Mejía Picazo, HJ, 2022) |
| "Levosimendan compared with milrinone did not reduce the occurrence rate of acute kidney injury in infants after total corrective heart surgery for atrioventricular septal defect, ventricular septal defect, or Tetralogy of Fallot." | 9.30 | The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. ( Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H, 2019) |
| "We conclude that milrinone is effective in the management of pulmonary hypertension following CPB in children who underwent TOF repair." | 7.70 | Effect of milrinone on postbypass pulmonary hypertension in children after tetralogy of Fallot repair. ( Chow, LH; Chu, CC; Lee, TY; Lin, SM; New, SH; Ting, CK; Tsai, SK; Tsou, MY, 2000) |
| "To compare levosimendan with milrinone to prevent low cardiac output syndrome in patients undergoing tetralogy of Fallot correction." | 5.51 | [Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot]. ( Dosta-Herrera, JJ; Gutiérrez-Riveroll, KI; Mejía Picazo, HJ, 2022) |
| "Levosimendan compared with milrinone did not reduce the occurrence rate of acute kidney injury in infants after total corrective heart surgery for atrioventricular septal defect, ventricular septal defect, or Tetralogy of Fallot." | 5.30 | The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. ( Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H, 2019) |
| "We conclude that milrinone is effective in the management of pulmonary hypertension following CPB in children who underwent TOF repair." | 3.70 | Effect of milrinone on postbypass pulmonary hypertension in children after tetralogy of Fallot repair. ( Chow, LH; Chu, CC; Lee, TY; Lin, SM; New, SH; Ting, CK; Tsai, SK; Tsou, MY, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gutiérrez-Riveroll, KI | 1 |
| Mejía Picazo, HJ | 1 |
| Dosta-Herrera, JJ | 1 |
| Thorlacius, EM | 1 |
| Suominen, PK | 1 |
| Wåhlander, H | 1 |
| Keski-Nisula, J | 1 |
| Vistnes, M | 1 |
| Ricksten, SE | 1 |
| Synnergren, M | 1 |
| Romlin, BS | 1 |
| Castellheim, A | 1 |
| Chu, CC | 1 |
| Lin, SM | 1 |
| New, SH | 1 |
| Ting, CK | 1 |
| Chow, LH | 1 |
| Tsou, MY | 1 |
| Tsai, SK | 1 |
| Lee, TY | 1 |
2 trials available for milrinone and Fallot's Tetralogy
| Article | Year |
|---|---|
[Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Longitudinal Studies; Milrinone; | 2022 |
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Creati | 2019 |
1 other study available for milrinone and Fallot's Tetralogy
| Article | Year |
|---|---|
Effect of milrinone on postbypass pulmonary hypertension in children after tetralogy of Fallot repair.
Topics: Adolescent; Adult; Cardiopulmonary Bypass; Child; Child, Preschool; Female; Humans; Hypertension, Pu | 2000 |